60 degrees pharmaceuticals, Inc.(SXTP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SXTP 60 degrees pharmaceuticals, Inc.

交易中 09-18 12:45:19 EDT

0.9624

-0.0302

-3.04%

最高0.9624	最低0.9203	成交量1.28万
今开0.9527	昨收0.9926	日振幅4.24%
总市值338.48万	流通市值170.54万	总股本351.70万
成交额1.21万	换手率0.72%	流通股本177.20万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SXTP","market":"US","secType":"STK","nameCN":"60 degrees pharmaceuticals, Inc.","latestPrice":0.9624,"timestamp":1789749539872,"preClose":0.9926,"halted":0,"volume":12774,"delay":0,"changeRate":-0.0304251460809994,"floatShares":1772000,"shares":3517000,"eps":-6.3166,"marketStatus":"交易中","change":-0.0302,"latestTime":"09-18 12:45:19 EDT","open":0.9527,"high":0.9624,"low":0.9203,"amount":12136.602948,"amplitude":0.042414,"askPrice":0.9911,"askSize":52,"bidPrice":0.9425,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-6.3166,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":0,"listingDate":1686801600000,"exchange":"NASDAQ","adjPreClose":0.9926,"preHourTrading":{"tag":"盘前","latestPrice":0.95,"preClose":0.9926,"latestTime":"07:00 EDT","volume":605,"amount":593.837024,"timestamp":1789729216118,"change":-0.0426,"changeRate":-0.042918,"amplitude":0.064578},"postHourTrading":{"tag":"盘后","latestPrice":0.9748,"preClose":0.9926,"latestTime":"19:44 EDT","volume":439,"amount":427.5107,"timestamp":1789688652289,"change":-0.0178,"changeRate":-0.017933,"amplitude":0.022768},"volumeRatio":0.237047},"requestUrl":"/m/hq/s/SXTP","defaultTab":"news","newsList":[{"id":"1149797615","title":"60 Degrees Pharmaceuticals 将就他非诺喹治疗巴贝斯虫病的新药申请路径，请求与FDA召开会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1149797615","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149797615?lang=zh_cn&edition=full","pubTime":"2026-07-30 05:00","pubTimestamp":1785358841,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals 公司计划就他非诺喹（Tafenoquine）用于治疗巴贝斯虫病（Babesiosis）的新药申请（NDA）路径，正式请求与美国食品药品监督管理局（FDA）举行会议。这一举措标志着该公司在推进该候选药物的监管进程中迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180936305","title":"60 Degrees Pharmaceuticals宣布住院巴贝斯虫病研究达到最低入组人数；中期数据解读计划于2026年10月6日前公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1180936305","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180936305?lang=zh_cn&edition=full","pubTime":"2026-07-30 04:05","pubTimestamp":1785355520,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals, Inc. 今日对外公布，其针对住院巴贝斯虫病患者的临床研究已成功达成最低入组人数这一关键里程碑。这一进展标志着该项目的推进迈出了坚实一步。\n公司同时明确，计划在2026年10月6日之前，对外发布该研究的中期数据解读。这一时间表的设定，为市场及医学界提供了清晰的预期。巴贝斯虫病作为一种罕见且可能危及生命的寄生虫感染，目前有效的治疗选择十分有限，因此这项研究的每一步进展都备受关注。\n围绕此项研究的后续动态，尤其是即将公布的中期数据，投资者和行业观察者都将予以密切关注。这些数据或将为评估相关治疗方案的潜力提供重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007","SXTPW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172283578","title":"60 Degrees Pharmaceuticals与佛罗里达州立大学达成独家期权协议，共同推进栗精胺用于蜱传疾病治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1172283578","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172283578?lang=zh_cn&edition=full","pubTime":"2026-07-08 20:03","pubTimestamp":1783512208,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals 宣布，已与佛罗里达州立大学签署一项独家期权协议，旨在共同推进化合物栗精胺（Castanospermine）用于治疗蜱传疾病的研发工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","SXTPW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115356434","title":"60 Degrees Pharmaceuticals宣布数据安全监测委员会对Tafenoquine治疗伴有重度疲劳的慢性巴贝斯虫病患者的B-free二期研究给予积极推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=1115356434","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115356434?lang=zh_cn&edition=full","pubTime":"2026-07-01 20:06","pubTimestamp":1782907607,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals宣布，其数据安全监测委员会已对使用Tafenoquine治疗伴有重度疲劳的慢性巴贝斯虫病患者的B-free二期研究给出了积极的推荐意见。这一进展标志着该药物在应对这一特定患者群体需求的研究道路上迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP","SXTPW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159924907","title":"60 Degrees Pharmaceuticals与佛罗里达州立大学签署独家专利许可协议，将澳大利亚栗子提取物作为植物补充剂非处方使用","url":"https://stock-news.laohu8.com/highlight/detail?id=1159924907","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159924907?lang=zh_cn&edition=full","pubTime":"2026-06-11 20:05","pubTimestamp":1781179544,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals已与佛罗里达州立大学达成一项独家专利许可协议，旨在将澳大利亚栗子提取物作为植物补充剂进行非处方用途的开发与商业化。该协议标志着公司在其产品管线拓展方面迈出了重要一步，为其在植物补充剂领域的布局提供了关键的技术和知识产权支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP","SXTPW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183362639","title":"60 Degrees Pharmaceuticals：有望在2028年第一季度末前向FDA提交他非诺喹新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1183362639","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183362639?lang=zh_cn&edition=full","pubTime":"2026-06-04 04:59","pubTimestamp":1780520371,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件，生物制药公司60 Degrees Pharmaceuticals, Inc.可能将在2028年第一季度结束前，向美国食品药品监督管理局提交其药物他非诺喹的新药申请。\n这份监管文件披露了公司关于该候选药物的最新进展时间表。他非诺喹是一种正在研发中的药物，其目标适应症尚未在文件中具体说明。\n若申请按计划提交，将标志着该药物研发过程中的一个重要监管里程碑。新药申请的提交是药物获准在美国市场上市销售的关键步骤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164428215","title":"60 Degrees Pharmaceuticals 宣布首个季节性患者提前入组他非诺喹治疗住院巴贝斯虫病的临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1164428215","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164428215?lang=zh_cn&edition=full","pubTime":"2026-05-26 20:02","pubTimestamp":1779796938,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals 宣布，其用于治疗住院巴贝斯虫病患者的他非诺喹临床试验，已提前完成首位季节性患者的入组工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTPW","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190705999","title":"60 Degrees Pharmaceuticals宣布疟疾预防药物Arakoda登陆Runway Health平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1190705999","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190705999?lang=zh_cn&edition=full","pubTime":"2026-04-15 20:05","pubTimestamp":1776254720,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals Inc. 近日宣布，其疟疾预防药物Arakoda已正式在Runway Health官方网站上线销售。Arakoda作为公司核心抗疟产品，此次渠道拓展标志着企业数字营销战略的重要突破。通过Runway Health的远程医疗服务，用户可完成在线问诊并获取处方，简化了传统购药流程。公司表示，这一举措契合后疫情时代数字医疗发展趋势，未来将继续探索与其他线上医疗平台的合作可能。目前Arakoda已在Runway Health平台开启预售，首批订单将于下周开始配送。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518627595","title":"60 Degrees Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518627595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518627595?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:41","pubTimestamp":1741617699,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时41分，60 Degrees Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.13%。60 Degrees Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3485.77%、753.31%、636.86%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.，振幅分别为41.36%、40.33%、40.24%。60 Degrees Pharmaceuticals, Inc.公司简介：60 Degrees Pharmaceuticals Inc作为一家专业制药公司运营，目标是利用生物科学和应用研究来开发和商业化预防和治疗传染病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022414096404721&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022414096404721&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516665908","title":"60 Degrees Pharmaceuticals, Inc.盘中异动 大幅跳水6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516665908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516665908?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:57","pubTimestamp":1741035437,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时57分，60 Degrees Pharmaceuticals, Inc.股票出现波动，股价大幅跳水6.06%。60 Degrees Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。60 Degrees Pharmaceuticals, Inc.公司简介：60 Degrees Pharmaceuticals Inc作为一家专业制药公司运营，目标是利用生物科学和应用研究来开发和商业化预防和治疗传染病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304045717989a64b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304045717989a64b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514382057","title":"60 Degrees Pharmaceuticals, Inc.盘中异动 大幅跳水5.38%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514382057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514382057?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:55","pubTimestamp":1740671735,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时55分，60 Degrees Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.38%。60 Degrees Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。60 Degrees Pharmaceuticals, Inc.公司简介：60 Degrees Pharmaceuticals Inc作为一家专业制药公司运营，目标是利用生物科学和应用研究来开发和商业化预防和治疗传染病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227235535abdf838a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227235535abdf838a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514562508","title":"60 Degrees Pharmaceuticals, Inc.盘中异动 大幅拉升6.77%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514562508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514562508?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580269,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分，60 Degrees Pharmaceuticals, Inc.股票出现波动，股价大幅上涨6.77%。60 Degrees Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。60 Degrees Pharmaceuticals, Inc.公司简介：60 Degrees Pharmaceuticals Inc作为一家专业制药公司运营，目标是利用生物科学和应用研究来开发和商业化预防和治疗传染病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622311096314f04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622311096314f04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514090406","title":"60 Degrees Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.19%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514090406?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:36","pubTimestamp":1740494179,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时36分，60 Degrees Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.19%。60 Degrees Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。60 Degrees Pharmaceuticals, Inc.公司简介：60 Degrees Pharmaceuticals Inc作为一家专业制药公司运营，目标是利用生物科学和应用研究来开发和商业化预防和治疗传染病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223619962ff3b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223619962ff3b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513279327","title":"60 Degrees Pharmaceuticals, Inc.盘中异动 急速跳水5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513279327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513279327?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:31","pubTimestamp":1740407518,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分，60 Degrees Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.33%。60 Degrees Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。60 Degrees Pharmaceuticals, Inc.公司简介：60 Degrees Pharmaceuticals Inc作为一家专业制药公司运营，目标是利用生物科学和应用研究来开发和商业化预防和治疗传染病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223158a252145b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223158a252145b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513296141","title":"60 Degrees Pharmaceuticals, Inc.盘中异动 快速下跌6.80%报0.440美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513296141?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:41","pubTimestamp":1740148860,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时41分，60 Degrees Pharmaceuticals, Inc.股票出现异动，股价急速下跌6.80%。60 Degrees Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。60 Degrees Pharmaceuticals, Inc.公司简介：60 Degrees Pharmaceuticals Inc作为一家专业制药公司运营，目标是利用生物科学和应用研究来开发和商业化预防和治疗传染病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224100abd7b1c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224100abd7b1c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMGAQ","OMGA","BK4539","SXTP","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512948272","title":"60 Degrees Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512948272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512948272?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:49","pubTimestamp":1739983778,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时49分，60 Degrees Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.21%。60 Degrees Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。60 Degrees Pharmaceuticals, Inc.公司简介：60 Degrees Pharmaceuticals Inc作为一家专业制药公司运营，目标是利用生物科学和应用研究来开发和商业化预防和治疗传染病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220004939988b47cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220004939988b47cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165263","title":"60 Degrees Pharmaceuticals, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165263?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:35","pubTimestamp":1739889317,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时35分，60 Degrees Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.23%。截至发稿，该股报0.560美元/股，成交量6.0326万股，换手率0.82%，振幅1.52%。60 Degrees Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。60 Degrees Pharmaceuticals, Inc.公司简介：60 Degrees Pharmaceuticals Inc作为一家专业制药公司运营，目标是利用生物科学和应用研究来开发和商业化预防和治疗传染病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182235179889fd70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182235179889fd70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511521372","title":"60 Degrees Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511521372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511521372?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:17","pubTimestamp":1739459827,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时17分，60 Degrees Pharmaceuticals, Inc.股票出现波动，股价快速下跌6.99%。60 Degrees Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。60 Degrees Pharmaceuticals, Inc.公司简介：60 Degrees Pharmaceuticals Inc作为一家专业制药公司运营，目标是利用生物科学和应用研究来开发和商业化预防和治疗传染病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021323170798843567&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021323170798843567&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380667","title":"60 Degrees Pharmaceuticals, Inc.盘中异动 早盘大幅跳水7.31%报0.561美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380667?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:31","pubTimestamp":1739284307,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时31分，60 Degrees Pharmaceuticals, Inc.股票出现异动，股价急速下挫7.31%。60 Degrees Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。60 Degrees Pharmaceuticals, Inc.公司简介：60 Degrees Pharmaceuticals Inc作为一家专业制药公司运营，目标是利用生物科学和应用研究来开发和商业化预防和治疗传染病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223147a241fb19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223147a241fb19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","OCEA","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510861643","title":"60 Degrees Pharmaceuticals, Inc.盘中异动 大幅上涨5.58%报0.585美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510861643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510861643?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:13","pubTimestamp":1739200433,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时13分，60 Degrees Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.58%。60 Degrees Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。60 Degrees Pharmaceuticals, Inc.公司简介：60 Degrees Pharmaceuticals Inc作为一家专业制药公司运营，目标是利用生物科学和应用研究来开发和商业化预防和治疗传染病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210231354abc9af6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210231354abc9af6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SXTP","BK4139","OCEA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.60degreespharma.com","stockEarnings":[{"period":"1week","weight":0.0673},{"period":"1month","weight":-0.1138},{"period":"3month","weight":-0.3948},{"period":"6month","weight":-0.491},{"period":"1year","weight":-0.8277},{"period":"ytd","weight":-0.5118}],"compareEarnings":[{"period":"1week","weight":0.0063},{"period":"1month","weight":-0.0063},{"period":"3month","weight":0.0212},{"period":"6month","weight":0.1758},{"period":"1year","weight":0.1569},{"period":"ytd","weight":0.1183}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"60 Degrees Pharmaceuticals, Inc.于2022年6月1日在特拉华州注册成立，此前与一家同名的有限责任公司合并。该公司是一家专业制药公司，专注于开发和商业化治疗传染病的疗法。其产品Arakoda（一种疟疾预防药物）自2019年起上市，其研发管线还包括其他虫媒、真菌和病毒性疾病项目。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.040319},{"month":2,"riseRate":0,"avgChangeRate":-0.262735},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.15171},{"month":4,"riseRate":0.333333,"avgChangeRate":0.079946},{"month":5,"riseRate":0.333333,"avgChangeRate":0.058798},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.011364},{"month":7,"riseRate":0,"avgChangeRate":-0.39553},{"month":8,"riseRate":0.25,"avgChangeRate":-0.160667},{"month":9,"riseRate":0.25,"avgChangeRate":-0.142459},{"month":10,"riseRate":0,"avgChangeRate":-0.229986},{"month":11,"riseRate":0.666667,"avgChangeRate":0.078807},{"month":12,"riseRate":0.666667,"avgChangeRate":0.11386}],"exchange":"NASDAQ","name":"60 degrees pharmaceuticals, Inc.","nameEN":"60 degrees pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"60 degrees pharmaceuticals, Inc.(SXTP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供60 degrees pharmaceuticals, Inc.(SXTP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"60 degrees pharmaceuticals, Inc.,SXTP,60 degrees pharmaceuticals, Inc.股票,60 degrees pharmaceuticals, Inc.股票老虎,60 degrees pharmaceuticals, Inc.股票老虎国际,60 degrees pharmaceuticals, Inc.行情,60 degrees pharmaceuticals, Inc.股票行情,60 degrees pharmaceuticals, Inc.股价,60 degrees pharmaceuticals, Inc.股市,60 degrees pharmaceuticals, Inc.股票价格,60 degrees pharmaceuticals, Inc.股票交易,60 degrees pharmaceuticals, Inc.股票购买,60 degrees pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"60 degrees pharmaceuticals, Inc.(SXTP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供60 degrees pharmaceuticals, Inc.(SXTP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}